Seeing Is Believing
MRSN is currently covered by 8 analysts with an average price target of $8.01. This is a potential upside of $5.84 (269.12%) from yesterday's end of day stock price of $2.17.
Mersana Therapeutics's activity chart (see below) currently has 36 price targets and 41 ratings on display. The stock rating distribution of MRSN is 58.82% BUY and 41.18% HOLD.
Analysts average stock forecasts to be materialized ratio is 32.78% with an average time for these price targets to be met of 248.92 days.
Highest price target for MRSN is $9, Lowest price target is $5, average price target is $8.01.
Most recent stock forecast was given by ASHIK KURIAN from CITI on 15-Nov-2024. First documented stock forecast 24-Jul-2017.
Currently out of the existing stock ratings of MRSN, 10 are a BUY (58.82%), 7 are a HOLD (41.18%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$2.96 (145.10%)
$1
11 days ago
(15-Nov-2024)
0/4 (0%)
$2.65 (112.77%)
Buy
$7
$4.96 (243.14%)
$2
8 months 28 days ago
(29-Feb-2024)
3/6 (50%)
$1.56 (28.68%)
191
Buy
$9
$6.96 (341.18%)
8 months 28 days ago
(29-Feb-2024)
0/2 (0%)
$3.56 (65.44%)
Buy
$7
$4.96 (243.14%)
$14
8 months 28 days ago
(29-Feb-2024)
1/3 (33.33%)
$1.56 (28.68%)
1072
Hold
$5
1 years 3 months 30 days ago
(27-Jul-2023)
2/3 (66.67%)
$1.46 (19.97%)
48
What is MRSN (Mersana Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?
Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?
Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?